BIOMARKER:

STK11 deletion + KRAS mutation

Entrez ID:

Related biomarkers:

‹

›

STK11 deletion + KRAS mutation STK11 deletion + KRAS mutation	Lung Adenocarcinoma LUAD	STK11 deletion + KRAS mutation STK11 deletion + KRAS mutation	Lung Adenocarcinoma LUAD	PD-L1 inhibitor Sensitive: C3 – Early Trials	PD-L1 inhibitor Sensitive: C3 – Early Trials
STK11 deletion + KRAS mutation STK11 deletion + KRAS mutation	Lung Adenocarcinoma LUAD	STK11 deletion + KRAS mutation STK11 deletion + KRAS mutation	Lung Adenocarcinoma LUAD	PD1 inhibitor Sensitive: C3 – Early Trials	PD1 inhibitor Sensitive: C3 – Early Trials
STK11 deletion + KRAS mutation STK11 deletion + KRAS mutation	Non Small Cell Lung Cancer NSCLC	STK11 deletion + KRAS mutation STK11 deletion + KRAS mutation	Non Small Cell Lung Cancer NSCLC	MEK inhibitor + sotorasib Sensitive: D – Preclinical	MEK inhibitor + sotorasib Sensitive: D – Preclinical
STK11 deletion + KRAS mutation STK11 deletion + KRAS mutation	Non Small Cell Lung Cancer NSCLC	STK11 deletion + KRAS mutation STK11 deletion + KRAS mutation	Non Small Cell Lung Cancer NSCLC	AMG 176 + MEK inhibitor Sensitive: D – Preclinical	AMG 176 + MEK inhibitor Sensitive: D – Preclinical